Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker NFLX
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Gregory K. Peters Co-CEO, Director | NFLX Netflix, Inc. | Sale | 27,312 | $63.62 | $1.7M Sale | Form 4 ↗ |
| Nov 4, 2026 | Theodore A. Sarandos Co-CEO, Director | NFLX Netflix, Inc. | Sale | 27,312 | $66.20 | $1.8M Sale | Form 4 ↗ |
| Nov 4, 2026 | Spencer Adam Neumann Chief Financial Officer | NFLX Netflix, Inc. | Sale | 9,253 | $66.15 | $612.1K Sale | Form 4 ↗ |
| Oct 26, 2026 | Bradford L. Smith Director | NFLX Netflix, Inc. | Sale | 4,200 | $65.14 | $273.6K Sale | Form 4 ↗ |
| Oct 26, 2026 | Bradford L. Smith Director | NFLX Netflix, Inc. | Sale | 1,800 | $64.61 | $116.3K Sale | Form 4 ↗ |
| Oct 26, 2026 | Bradford L. Smith Director | NFLX Netflix, Inc. | Sale | 11,980 | $63.55 | $761.3K Sale | Form 4 ↗ |
| Sep 10, 2026 | Richard N. Barton Director | NFLX Netflix, Inc. | Sale | 720 | $75.27 | $54.2K Sale | Form 4 ↗ |
| Sep 9, 2026 | Richard N. Barton Director | NFLX Netflix, Inc. | Sale | 720 | $76.26 | $54.9K Sale | Form 4 ↗ |
| Sep 8, 2026 | Richard N. Barton Director | NFLX Netflix, Inc. | Sale | 720 | $77.60 | $55.9K Sale | Form 4 ↗ |
| Aug 10, 2026 | Spencer Adam Neumann Chief Financial Officer | NFLX Netflix, Inc. | Sale | 9,248 | $75.79 | $700.9K Sale | Form 4 ↗ |
| Aug 6, 2026 | Gregory K. Peters Co-CEO, Director | NFLX Netflix, Inc. | Sale | 27,312 | $73.54 | $2.0M Sale | Form 4 ↗ |
| Aug 5, 2026 | Richard N. Barton Director | NFLX Netflix, Inc. | Sale | 2,160 | $75.10 | $162.2K Sale | Form 4 ↗ |
| Aug 4, 2026 | David A. Hyman Chief Legal Officer | NFLX Netflix, Inc. | Sale | 5,723 | $72.85 | $416.9K Sale | Form 4 ↗ |
| Aug 4, 2026 | Theodore A. Sarandos Co-CEO, Director | NFLX Netflix, Inc. | Sale | 27,312 | $73.35 | $2.0M Sale | Form 4 ↗ |
| Aug 3, 2026 | Theodore A. Sarandos Co-CEO, Director | NFLX Netflix, Inc. | Sale | 23,959 | $73.48 | $1.8M Sale | Form 4 ↗ |
| Aug 3, 2026 | Theodore A. Sarandos Co-CEO, Director | NFLX Netflix, Inc. | Sale | 81,891 | $72.90 | $6.0M Sale | Form 4 ↗ |
| Jun 17, 2026 | Bradford L. Smith Director | NFLX Netflix, Inc. | Sale | 13,800 | $78.01 | $1.1M Sale | Form 4 ↗ |
| Jun 17, 2026 | Bradford L. Smith Director | NFLX Netflix, Inc. | Sale | 22,190 | $77.21 | $1.7M Sale | Form 4 ↗ |
| Jun 1, 2026 | Reed Hastings Director | NFLX Netflix, Inc. | Sale | 53,783 | $86.73 | $4.7M Sale | Form 4 ↗ |
| Jun 1, 2026 | Reed Hastings Director | NFLX Netflix, Inc. | Sale | 332,917 | $85.85 | $28.6M Sale | Form 4 ↗ |
| May 7, 2026 | Gregory K. Peters Co-CEO, Director | NFLX Netflix, Inc. | Sale | 27,312 | $88.69 | $2.4M Sale | Form 4 ↗ |
| May 7, 2026 | Spencer Adam Neumann Chief Financial Officer | NFLX Netflix, Inc. | Sale | 9,253 | $88.95 | $823.1K Sale | Form 4 ↗ |
| May 5, 2026 | Theodore A. Sarandos Co-CEO, Director | NFLX Netflix, Inc. | Sale | 7,039 | $87.98 | $619.3K Sale | Form 4 ↗ |
| May 5, 2026 | Theodore A. Sarandos Co-CEO, Director | NFLX Netflix, Inc. | Sale | 7,256 | $87.97 | $638.3K Sale | Form 4 ↗ |
| May 5, 2026 | Theodore A. Sarandos Co-CEO, Director | NFLX Netflix, Inc. | Sale | 13,017 | $87.96 | $1.1M Sale | Form 4 ↗ |
| May 5, 2026 | David A. Hyman Chief Legal Officer | NFLX Netflix, Inc. | Sale | 5,722 | $88.08 | $504.0K Sale | Form 4 ↗ |
| May 1, 2026 | Reed Hastings Director | NFLX Netflix, Inc. | Sale | 113,334 | $94.17 | $10.7M Sale | Form 4 ↗ |
| May 1, 2026 | Reed Hastings Director | NFLX Netflix, Inc. | Sale | 105,791 | $93.54 | $9.9M Sale | Form 4 ↗ |
| May 1, 2026 | Reed Hastings Director | NFLX Netflix, Inc. | Sale | 188,425 | $92.28 | $17.4M Sale | Form 4 ↗ |
| Apr 2, 2026 | Spencer Adam Neumann Chief Financial Officer | NFLX Netflix, Inc. | Sale | 28,630 | $98.00 | $2.8M Sale | Form 4 ↗ |
| Apr 1, 2026 | Reed Hastings Director | NFLX Netflix, Inc. | Sale | 20,580 | $96.66 | $2.0M Sale | Form 4 ↗ |
| Apr 1, 2026 | Reed Hastings Director | NFLX Netflix, Inc. | Sale | 247,923 | $95.68 | $23.7M Sale | Form 4 ↗ |
| Apr 1, 2026 | Reed Hastings Director | NFLX Netflix, Inc. | Sale | 152,047 | $95.02 | $14.4M Sale | Form 4 ↗ |
| Mar 2, 2026 | Spencer Adam Neumann Chief Financial Officer | NFLX Netflix, Inc. | Sale | 28,630 | $97.00 | $2.8M Sale | Form 4 ↗ |
| Mar 2, 2026 | Reed Hastings Director | NFLX Netflix, Inc. | Sale | 128,189 | $97.59 | $12.5M Sale | Form 4 ↗ |
| Mar 2, 2026 | Reed Hastings Director | NFLX Netflix, Inc. | Sale | 227,680 | $96.92 | $22.1M Sale | Form 4 ↗ |
| Mar 2, 2026 | Reed Hastings Director | NFLX Netflix, Inc. | Sale | 54,681 | $96.06 | $5.3M Sale | Form 4 ↗ |
| Feb 27, 2026 | Spencer Adam Neumann Chief Financial Officer | NFLX Netflix, Inc. | Sale | 28,630 | $96.00 | $2.7M Sale | Form 4 ↗ |
| Feb 27, 2026 | Spencer Adam Neumann Chief Financial Officer | NFLX Netflix, Inc. | Sale | 28,630 | $95.00 | $2.7M Sale | Form 4 ↗ |
| Feb 10, 2026 | Gregory K. Peters Co-CEO, Director | NFLX Netflix, Inc. | Sale | 1,310 | $84.40 | $110.6K Sale | Form 4 ↗ |
| Feb 10, 2026 | Gregory K. Peters Co-CEO, Director | NFLX Netflix, Inc. | Sale | 11,283 | $83.76 | $945.1K Sale | Form 4 ↗ |
| Feb 10, 2026 | Gregory K. Peters Co-CEO, Director | NFLX Netflix, Inc. | Sale | 14,719 | $82.74 | $1.2M Sale | Form 4 ↗ |
| Feb 10, 2026 | Cletus R. Willems Chief Global Affairs Officer | NFLX Netflix, Inc. | Sale | 3,136 | $82.67 | $259.3K Sale | Form 4 ↗ |
| Feb 9, 2026 | David A. Hyman Chief Legal Officer | NFLX Netflix, Inc. | Sale | 5,727 | $81.06 | $464.2K Sale | Form 4 ↗ |
| Feb 6, 2026 | Spencer Adam Neumann Chief Financial Officer | NFLX Netflix, Inc. | Sale | 9,248 | $81.27 | $751.6K Sale | Form 4 ↗ |
| Feb 2, 2026 | Reed Hastings Director | NFLX Netflix, Inc. | Sale | 38,620 | $84.96 | $3.3M Sale | Form 4 ↗ |
| Feb 2, 2026 | Reed Hastings Director | NFLX Netflix, Inc. | Sale | 104,594 | $84.09 | $8.8M Sale | Form 4 ↗ |
| Feb 2, 2026 | Reed Hastings Director | NFLX Netflix, Inc. | Sale | 247,756 | $83.22 | $20.6M Sale | Form 4 ↗ |
| Jan 29, 2026 | Gregory K. Peters Co-CEO, Director | NFLX Netflix, Inc. | Sale | 7,560 | $83.75 | $633.1K Sale | Form 4 ↗ |
| Jan 29, 2026 | Gregory K. Peters Co-CEO, Director | NFLX Netflix, Inc. | Sale | 98,221 | $82.87 | $8.1M Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:40 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances